Sarah Anis, MD
Ophthalmology · Providence, RINPI 1225276678
Payments from drug & device makers
Across 537 payments — averaging $304.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$72K
- Aerie Pharmaceuticals, Inc.$40K
- Alcon$35K
- NEW World Medical,inc.$7K
- Glaukos Corporation$5K
- Bausch & Lomb Americas Inc.$1K
- plus $2K from 16 others
Across 1 payment — averaging $8000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ivantis, Inc$8K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 242 | $71,852 |
| Aerie Pharmaceuticals, Inc. | 69 | $40,133 |
| Alcon | 82 | $35,470 |
| NEW World Medical,inc. | 32 | $6,899 |
| Glaukos Corporation | 16 | $5,112 |
| Bausch & Lomb Americas Inc. | 12 | $1,358 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 16 | $827 |
| Sight Sciences, Inc. | 14 | $348 |
| Kala Pharmaceuticals, Inc. | 14 | $265 |
| Astellas Pharma US Inc | 3 | $193 |
| Thea Pharma Inc. | 8 | $168 |
| Novartis | 4 | $160 |
| Amgen(2 entities) | 7 | $126 |
| ANI Pharmaceuticals, Inc. | 5 | $94 |
| AstraZeneca | 1 | $88 |
| Sun Pharmaceutical Industries Inc. | 4 | $68 |
| Apellis Pharmaceuticals, Inc. | 2 | $54 |
| Akorn Operating Company LLC | 2 | $37 |
| Oyster Point Pharma, Inc. | 1 | $20 |
| Vyera Pharmaceuticals, LLC | 1 | $18 |
| Rayner Intraocular Lenses Limited | 1 | $18 |
| Eyepoint US, Inc. | 1 | $14 |
How this compares
$163,320 in reported general payments places this provider in the 95th percentile of 69 ophthalmology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Providence
- Lory Snady-MccoyProvidence$57K
- Jesse RichmanProvidence$30K
- Yoash EnzerProvidence$11K
- David TienProvidence$6K
- Jane CookProvidence$4K
- Christopher NewtonProvidence$3K
- Joseph DucharmeProvidence$3K
- King ToProvidence$2K
- Gaurav GuptaProvidence$2K
- Carolina ChiouProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.